Indiana University-Purdue University Indianapolis (IUPUI) / Background: Bacterial adherence to the acquired dental pellicle, important in caries, is mediated by receptor-adhesin interactions such as Streptococcus mutans antigen I/II (I/II). Ten I/II epitopes from the A, V, P and C regions were chosen to determine their reactivity in human saliva. Underlying the body’s ability to immunologically respond to bacteria that lead to caries are the human leukocyte antigen (HLA) genes, specifically HLA class II (HLA-II) genes that control antigen presentation. Previous studies suggested that a specific HLA biomarker group (HLA-DRB1*04) may have differential control of immune responses to I/II. However, it was not known whether secretory IgA (SIgA) responses to the selected epitopes from HLA-DRB1*04 positive subjects were different compared to their non-biomarker counterparts (negative), or across other caries factors, since no study to date had thus assessed these questions. Methods: Per IRB approval, the study population was divided into age, sex and race matched DRB1*04 positive (n=16) and negative groups (n=16). SIgA-epitope (and whole cell) reactivity was determined using ELISA. Other caries factors were measured. Subjects received a clinical exam by a trained examiner. ix Differences between DRB1*04 positive and negative groups were examined using a two-sided, two-sample t-test. Results: DRB1*04 positive subjects had numerically, but not statistically, higher reactivity to 9 out of 10 epitopes, the exception being residues 834-853 from the V and P regions of I/II across multiple measures. Though statistically insignificant, DRB1*04 positive subjects also exhibited 25-30 μg mL-1 less total IgA (TIgA) than negative counterparts. All clinical caries data proved inconclusive when comparing groups, likely due to exogenous factors and sample size. Conclusion: DRB1*04 positive subjects showed a trend toward lower TIgA. Moreover, they also showed a lower SIgA response across multiple measures to 834-853, the I/II V and P region epitope. This region forms a sort of functional epicenter involved in collaboration between domains along the entire I/II antigen, and governs the region involved in initial attachment to the acquired dental pellicle. This region may be involved in an in vivo discontinuous conformationally specific immunogenic epitope that serves as an HLA-II binding motif which remains elusive.

La perturbation de la barrière hémo-encéphalique et la migration des lymphocytes de la périphérie vers le système nerveux central (SNC) sont des événements précoces dans la formation des lésions cérébrales de sclérose en plaques (SEP). Dans ce contexte, les lymphocytes passent au travers des barrières hémo-encéphalique ou hémo-méningée pour atteindre le SNC et sont des contributeurs importants dans l’inflammation et les dommages tissulaires. Pour migrer à travers les barrières du SNC, les lymphocytes pathogéniques expriment des molécules d’adhérence. Identifier les acteurs clés à la migration des lymphocytes pathogéniques en estimant la contribution des molécules d’adhérence dans ce processus est la prochaine étape pour le développement de thérapies pour traiter la SEP. L’objectif de ce projet est d’explorer le rôle de deux molécules d’adhérence que sont ALCAM (de l’anglais : activated leukocytes cell adhesion molecule) et DICAM (de l’anglais : dual immunoglobulin domain containing cell adhesion molecule) dans la migration des lymphocytes pathogéniques vers le SNC pendant la SEP. Notre objectif principal se subdivise en deux sous-objectifs. En premier, notre but est de caractériser le rôle d’ALCAM dans le passage des lymphocytes B à travers les barrières du SNC dans un contexte neuroinflammatoire. En second, nous explorons le rôle de DICAM dans la migration des lymphocytes T auxiliaires 17 (TH17) vers le SNC en neuroinflammation. Nous faisons l’hypothèse qu’ALCAM contribue à la migration des lymphocytes B vers le SNC et que DICAM est impliqué dans la migration des lymphocytes TH17 à travers la barrière hémo-encéphalique pendant la SEP. Ces molécules d’adhérence seraient alors impliquées dans la pathogenèse de la SEP et seraient de potentielles cibles thérapeutiques pour traiter cette maladie. Nous avons d’abord utilisé une combinaison de spectrométrie de masse, PCR quantitative, cytométrie de flux et microscopie afin d’explorer l’expression de chacune de ses deux molécules d’adhérence sur les lymphocytes d’intérêt périphériques ex vivo ou différenciés in vitro. Des analyses en cytométrie en flux et microscopie nous ont permis de caractériser leur expression dans le sang périphérique et dans les lésions cérébrales de personnes atteintes de SEP. Ensuite, les expériences d’adhérence en flux et de migration in vitro effectuées en déplétant la molécule d’adhérence d’intérêt ont permis de mettre en évidence leur rôle dans différentes étapes de la migration des lymphocytes à travers les cellules endothéliales des barrières du SNC. Pour finir, le traitement de plusieurs modèles murins de SEP, appelés EAE (de l’anglais : experimental autoimmune encephalomyelitis), avec des anticorps bloquant anti-ALCAM ou anti-DICAM ont permis d’explorer le potentiel effet de tels traitements sur la sévérité de la maladie. Dans la première étude, nos résultats montrent qu’ALCAM est préférentiellement exprimée par les lymphocytes B pro-inflammatoires, mémoires et effecteurs au potentiel pathogénique. En tant que molécule d’adhérence, ALCAM contribue à leur migration à travers les cellules endothéliales des barrières hémo-encéphalique et hémo-méningée chez la souris et l’humain. De plus, nos expériences ont permis de montrer que la fréquence de lymphocytes B ALCAM+ est augmentée dans le sang périphérique des personnes atteintes de SEP et ces cellules sont aussi présentes dans les lésions et les infiltrats méningées en SEP. Finalement, bloquer ALCAM in vivo réduit la sévérité de la maladie EAE en diminuant l’infiltration des lymphocytes B au SNC. Dans la seconde étude, nous avons montré que parmi les sous-types de lymphocytes TH, DICAM est préférentiellement exprimée par les lymphocytes TH17. Dans les lésions de SEP, DICAM et son ligand αVβ3 co-localisent avec des marqueurs de cellules endothéliales suggérant que ces deux molécules pourraient être présentées à la lumière des vaisseaux aux lymphocytes TH17 circulants. Dans le sang périphérique, la fréquence de lymphocytes T CD4+ exprimant DICAM est augmentée chez les personnes atteintes de SEP et cette augmentation corrèle avec l’activité de la maladie. Nos expériences ont montré que DICAM est impliquée dans l’adhérence, l’arrêt et la diapédèse des lymphocytes TH17 à travers les cellules endothéliales de la barrière hémo-encéphalique in vitro et in vivo. Finalement, le traitement de souris EAE avec un anticorps bloquant DICAM permet de réduire la sévérité de la maladie et diminue la migration des lymphocytes TH17 vers le SNC. Nos résultats indiquent un rôle d’ALCAM dans la migration des lymphocytes B et que DICAM, préférentiellement exprimé par les TH17, médie leur migration vers le SNC. Bloquer ALCAM ou DICAM sont deux stratégies permettant de réduire l’accès au SNC de différents sous-types de cellules pathogéniques pendant la neuroinflammation. Ainsi, elles sont toutes deux de potentielles cibles thérapeutiques pour réduire la sévérité et la progression de la SEP. / Disruption of the blood-brain barrier and migration of lymphocytes from the periphery to the central nervous system (CNS) are early events in lesion formation during multiple sclerosis (MS). Lymphocytes readily cross the blood-brain barrier (BBB) and the blood-meningeal barrier (BMB) to infiltrate the CNS and are important contributors to inflammation and tissue damage. To migrate through the brain barriers, pathogenic lymphocytes express adhesion molecules. Identifying key players in lymphocyte migration by understanding the role of adhesion molecules is the next step to develop novel therapies to treat MS. The objective of this project is to explore the role of two distinct adhesion molecules ALCAM (activated leukocytes cell adhesion molecule) and DICAM (dual immunoglobulin domain containing cell adhesion molecule) in pathogenic lymphocytes migration to the CNS during MS. This thesis subdivides in two main objectives. First, we aim to characterize ALCAM role in B lymphocyte migration to the CNS during neuroinflammation. Second, we aim to explore DICAM role in T helper 17 (TH17) lymphocytes migration to the CNS in neuroinflammation. We hypothesized that ALCAM plays a role in B lymphocytes migration to the CNS during MS and that DICAM is involved in TH17 lymphocytes migration through the blood-brain barrier during MS. Those adhesion molecules might be involved in MS pathogenesis and therefore could become new therapeutic targets to treat MS. We first used mass spectrometry, quantitative PCR, flow cytometry and confocal microscopy to explore expression profiles of ALCAM and DICAM by peripheral lymphocytes subpopulations ex vivo and differentiated in vitro. Flow cytometry and confocal microscopy analysis also revealed how those adhesion molecules are expressed by lymphocytes in peripheral blood and brain lesions of people living with MS. Then, we performed flow adhesion and migration assay of lymphocytes depleted for the adhesion molecule of interest allowing us to address their role in multitstep migration process through brain barriers endothelial cells. Finally, using five distinct murine experimental autoimmune encephalomyelitis models (EAE), we explored how blocking ALCAM or DICAM in vivo could affect lymphocytes migration to the SNC and disease severity. In the first manuscript, we described that ALCAM is preferentially expressed by B lymphocytes with memory, pro-inflammatory and effector phenotypes. Functionally, ALCAM is involved in B lymphocyte migration through both the BBB and the BMB in mouse and human. Interestingly, we showed that ALCAM expressing B lymphocytes are increased in peripheral blood of people living with MS and they are recovered in meningeal and parenchymal MS lesions. Last, blocking ALCAM in vivo alleviates EAE severity by reducing B lymphocyte infiltration to the CNS. In the second manuscript, we showed that TH17 lymphocytes preferentially express DICAM and can adhere both to DICAM and its ligand αVβ3. Moreover, DICAM and αVβ3 are both overexpressed by inflamed brain endothelial cells. In MS lesions, we described that both molecules colocalize with endothelial cell markers suggesting that it could be presented to the vessel lumen to the circulating TH17 lymphocytes. In peripheral blood, we showed that DICAM+ memory CD4+ T lymphocytes frequency is increased in people living with MS and it correlates with active form of the disease. Then, we described DICAM as a player in TH17 lymphocyte adhesion, arrest and migration through BBB endothelial cells in vitro and in vivo. Last, we showed that treating mice with a neutralizing DICAM antibody in several distinct models of EAE, reduced disease severity and TH17 cell migration to the SNC. Our data provide evidence of the role of ALCAM in memory B lymphocyte migration and that DICAM is preferentially expressed by TH17 cells and mediate their migration to the CNS during neuroinflammation. Collectively, our findings indicate that blocking ALCAM or DICAM are two ways to restrict different pathogenic cells access to the CNS during neuroinflammation and thus potentially to reduce the severity and worsening of a disease like MS.

O aumento da prevalência de doenças alérgicas como a asma, tem sido atribuído à falta de estímulos infecciosos. A atopia, que embasa as manifestações alérgicas, caracteriza-se por uma disfunção imune com predomínio da resposta do tipo Th2. Experimentos em modelos animais com micobactérias e seus produtos têm demonstrado resultados promissores na proteção e reversão de resposta imune do tipo Th2. A imunoterapia para alérgenos inalatórios tem mostrado resultados positivos e o uso do BCG como adjuvante poderia trazer benefícios adicionais. Em estudo randomizado duplo cego foram avaliados 21 indivíduos de ambos os sexos, com idades de 8 a 17 anos sensibilizados ao Dermatophagoides pteronissynus (Dpt) e portadores de asma leve ou moderada persistentes. Os pacientes foram divididos em dois grupos e tratados com imunoterapia específica (ITE) para Dpt. O Grupo A recebeu como adjuvante, no início da ITE, uma aplicação do diluente do BCG e o Grupo B uma dose da vacina BCG. Na avaliação realizada após o período de indução da ITE constatou-se nos dois grupos diminuição significativa dos sintomas, da necessidade de medicação para asma, da hiperreatividade brônquica inespecífica, da reatividade cutânea ao Dpt juntamente com a melhora da função pulmonar. Houve uma redução no índice de estimulação da cultura de células mononucleares do sangue periférico estimuladas com Dpt, acompanhada de uma elevação da IL-10 no sobrenadante e dos níveis da IgG específica para Dpt e da IgE total. Os eosinófilos, a IgE específica para Dpt do sangue e o óxido nítrico no ar exalado não se alteraram. Não houve diferença na comparação dentre os grupos, exceto na proliferação das células mononucleares do sangue periférico estimuladas com PPD, que foi maior no Grupo B. Conclusão: a ITE levou a resultados satisfatórios com melhora clínica e alterações imunológicas já ao final do período de indução. A avaliação do uso do BCG como adjuvante, não mostrou benefícios adicionais. / The increase of allergic diseases, such as asthma, has often been explained by a decline in infectious stimulation. Atopy that is characterized as an immune dysfunction promotes a strong type Th2 immune response and underlines allergic diseases. Experimental animal models researches with mycobacteria and its products had led to promising results in prevention or reversion of type Th2 response. Positive results have been obtained to allergens specific immunotherapy (SIT) and its association with BCG vaccine, as an adjuvant, could promote additional benefits. In a randomized double blind study 21 patients sensitized to mite Dermatophagoides pteronyssinus (Dpt) with mild or moderate persistent asthma, aged 8 to 17 years of both sex were evaluated. Patients were divided in two groups. Group A received at the beginning of SIT one dose of BCG diluent and Group B one dose of BCG vaccine. After the SIT induction period we observed in both groups a significant decrease in asthma symptoms, bronchial hyperreactivity, immediate cutaneous reactivity to Dpt and the necessity of drugs intake. Specific lymphoproliferation against Dpt significantly decreased while IL-10 levels, specific IgG and total IgE increased. Blood eosinophils, specific IgE, others immunoglobulins levels and nitric oxide in exhaled air didn\'t change. There were no differences in all parameters evaluated between the two groups except on specific lymphoproliferation against PPD that was higher in Group B. Conclusions: improvement in symptoms and immunologicals changes where observed at the end of SIT induction period. BCG as adjuvant didn\'t add additional benefits.

O aumento da prevalência de doenças alérgicas como a asma, tem sido atribuído à falta de estímulos infecciosos. A atopia, que embasa as manifestações alérgicas, caracteriza-se por uma disfunção imune com predomínio da resposta do tipo Th2. Experimentos em modelos animais com micobactérias e seus produtos têm demonstrado resultados promissores na proteção e reversão de resposta imune do tipo Th2. A imunoterapia para alérgenos inalatórios tem mostrado resultados positivos e o uso do BCG como adjuvante poderia trazer benefícios adicionais. Em estudo randomizado duplo cego foram avaliados 21 indivíduos de ambos os sexos, com idades de 8 a 17 anos sensibilizados ao Dermatophagoides pteronissynus (Dpt) e portadores de asma leve ou moderada persistentes. Os pacientes foram divididos em dois grupos e tratados com imunoterapia específica (ITE) para Dpt. O Grupo A recebeu como adjuvante, no início da ITE, uma aplicação do diluente do BCG e o Grupo B uma dose da vacina BCG. Na avaliação realizada após o período de indução da ITE constatou-se nos dois grupos diminuição significativa dos sintomas, da necessidade de medicação para asma, da hiperreatividade brônquica inespecífica, da reatividade cutânea ao Dpt juntamente com a melhora da função pulmonar. Houve uma redução no índice de estimulação da cultura de células mononucleares do sangue periférico estimuladas com Dpt, acompanhada de uma elevação da IL-10 no sobrenadante e dos níveis da IgG específica para Dpt e da IgE total. Os eosinófilos, a IgE específica para Dpt do sangue e o óxido nítrico no ar exalado não se alteraram. Não houve diferença na comparação dentre os grupos, exceto na proliferação das células mononucleares do sangue periférico estimuladas com PPD, que foi maior no Grupo B. Conclusão: a ITE levou a resultados satisfatórios com melhora clínica e alterações imunológicas já ao final do período de indução. A avaliação do uso do BCG como adjuvante, não mostrou benefícios adicionais. / The increase of allergic diseases, such as asthma, has often been explained by a decline in infectious stimulation. Atopy that is characterized as an immune dysfunction promotes a strong type Th2 immune response and underlines allergic diseases. Experimental animal models researches with mycobacteria and its products had led to promising results in prevention or reversion of type Th2 response. Positive results have been obtained to allergens specific immunotherapy (SIT) and its association with BCG vaccine, as an adjuvant, could promote additional benefits. In a randomized double blind study 21 patients sensitized to mite Dermatophagoides pteronyssinus (Dpt) with mild or moderate persistent asthma, aged 8 to 17 years of both sex were evaluated. Patients were divided in two groups. Group A received at the beginning of SIT one dose of BCG diluent and Group B one dose of BCG vaccine. After the SIT induction period we observed in both groups a significant decrease in asthma symptoms, bronchial hyperreactivity, immediate cutaneous reactivity to Dpt and the necessity of drugs intake. Specific lymphoproliferation against Dpt significantly decreased while IL-10 levels, specific IgG and total IgE increased. Blood eosinophils, specific IgE, others immunoglobulins levels and nitric oxide in exhaled air didn\'t change. There were no differences in all parameters evaluated between the two groups except on specific lymphoproliferation against PPD that was higher in Group B. Conclusions: improvement in symptoms and immunologicals changes where observed at the end of SIT induction period. BCG as adjuvant didn\'t add additional benefits.

Thesis (Ph. D.)--Uniformed Services University of the Health Sciences, 2005. / Typescript (photocopy).

Tesis por compendio / [ES] La producción en acuicultura se ha visto menguada por aparición de enfermedades en los sistemas de cría de peces. En concreto, en la dorada (Sparus aurata), hay dos parásitos destacados: Enteromyxum leei (Myxozoa) y Enterospora nucleophila (Microsporidia). Hasta la fecha, para ninguno de los dos se ha establecido un cultivo in vitro, y solo para E. leei se ha conseguido establecer un modelo de mantenimiento de la infección in vivo. La presente tesis pretende incrementar el conocimiento sobre estos parásitos y sus relaciones con el hospedador, sentando las bases para generar soluciones que puedan ser aplicadas en la acuicultura. El objetivo con E. leei fue estudiar la inmunidad adquirida inducida en la dorada y la posibilidad de generar herramientas de diagnóstico y vacunas frente a esta enfermedad. Para ello, primero se demostró la resistencia del pez al parásito tras una segunda exposición, la cual duró hasta 16 meses. Además, la resistencia parece estar correlacionada con altos niveles de inmunoglobulina (Ig) M específica en sangre, y una alta expresión de Igs, incluso antes de la re-exposición al parásito. El siguiente paso fue afinar el protocolo de infección con E. leei. Los resultados mostraron que una semana es suficiente para transmitir la infección de E. leei por efluente, independientemente de la temperatura. Tras la demostración de la respuesta adaptativa eficaz frente a E. leei, y al disponer de un modelo de infección refinado, se realizó un ensayo de inmunización pasiva. Aquí, los resultados mostraron que los anticuerpos especi'ficos efectivamente consigue ralentizar la invasión del intestino por el parásito y disminuir los síntomas de la enfermedad. Paralelamente, el resultado del análisis del repertorio de las regiones variables de la IgM e IgT del intestino peces resistentes mostró la inducción de una respuesta policlonal en las ce'lulas B. En base a estos resultados, se realizó una búsqueda de antígenos de E. leei que pudieran ser utilizados como candidatos para la producción de vacunas (análisis proteómico) o herramientas de diagnóstico (análisis in silico). Para ello, se ensambló un transcriptoma de novo utilizando una muestra mixta de intestino de dorada y parásito. Los resultados dieron lugar a 7 y 12 candidatos en la búsqueda in silico y proteómica, respectivamente. En los estudios de E. nucleophila, debido a que fue descrita muy recientemente, el punto de partida fue más básico. Las muestras de este parásito solo se pueden obtener de brotes naturales en piscifactorias. Por ello, primero se realizó un estudio de caracterización de la patología de la infección a partir de peces infectados naturalmente. En etapas tempranas de la infección, el parásito se localiza principalmente en el intestino, pero meses después, la prevalencia en intestino baja e incrementa en los órganos hematopoyéticos y el esto'mago. Los signos clínicos de la infección consistieron en una reducción significativa del crecimiento, emaciación, y palidez de las paredes intestinales. A nivel celular, en los casos ma's graves se observó hipercelularidad en el epitelio intestinal y proliferación de ce'lulas rodlet, un elevado número de linfocitos en la base del epitelio e infiltración de granulocitos acidófilos en el epitelio intestinal. Finalmente se probaron varias formas de transmisión horizontal de E. nucleophila (cohabitación, efluente, intubación oral y anal) con para desarrollar un modelo de mantenimiento in vivo. Se consiguió la transmisión el parásito por todas las vías, pero con una disminución de prevalencia a lo largo del tiempo. Variables como la temperatura, la dosis, y el estado de los peces donantes parecen ser más determinantes que la ruta seleccionada para la transmisión. Entre las rutas probadas, la intubación anal parece ser la más prometedora, pero ninguna de ellas fue capaz de reproducir los signos clínicos observados en las infecciones naturales. / [CA] La producció en aqüicultura s'ha vist minvada per aparició de malalties en els sistemes de cria de peixos. En concret, en l'orada (Sparus aurata), hi ha dos paràsits destacats: Enteromyxum leei (Myxozoa) i Enterospora nucleophila (Microsporidia). Fins avui, per a cap dels dos s'ha establert un cultiu in vitro, i només per a E. leei s'ha aconseguit establir un model de manteniment de la infecció in vivo. La present tesi pretén incrementar el coneixement sobre aquests paràsits i les seves relacions amb l'hoste, establint les bases per a generar solucions que puguin ser aplicades en l'aqüicultura. L'objectiu amb E. leei va ser estudiar la immunitat adquirida induïda en l'orada i la possibilitat de generar eines de diagnòstic i vacunes enfront d'aquesta malaltia. Per a això, primer es va demostrar la resistència del peix al paràsit després d'una segona exposició, la qual va durar fins a 16 mesos. A més, la resistència sembla estar correlacionada amb alts nivells d'immunoglobulina (Ig) M específica en sang, i una alta expressió de Igs, fins i tot abans de la re-exposició al paràsit. El següent pas va ser afinar el protocol d'infecció amb E. leei. Els resultats van mostrar que una setmana és suficient per a transmetre la infecció de E. leei per efluent, independentment de la temperatura. Després de la demostració de la resposta adaptativa eficaç enfront de E. leei, i en disposar d'un model d'infecció refinat, es va realitzar un assaig d'immunització passiva. Aquí, els resultats van mostrar que els anticossos específics efectivament aconsegueix alentir la invasió de l'intestí pel paràsit i disminuir els símptomes de la malaltia. Paral·lelament, el resultat de l'anàlisi del repertori de les regions variables de la IgM i IgT de l'intestí peixos resistents va mostrar la inducció d'una resposta policlonal en les cèl·lules B. Sobre la base d'aquests resultats, es va realitzar una cerca d'antígens de E. leei que poguessin ser utilitzats com a candidats per a la producció de vacunes (anàlisis proteómico) o eines de diagnòstic (anàlisi in silico). Per a això, es va assemblar un transcriptoma de novo utilitzant una mostra mixta d'intestí d'orada i paràsit. Els resultats van donar lloc a 7 i 12 candidats en la cerca in silico i proteòmica, respectivament. En els estudis de E. nucleophila, pel fet que va ser descrita molt recentment, el punt de partida va ser més bàsic. Les mostres d'aquest paràsit només es poden obtenir de brots naturals en piscifactorias. Per això, primer es va realitzar un estudi de caracterització de la patologia de la infecció a partir de peixos infectats naturalment. En etapes primerenques de la infecció, el paràsit es localitza principalment en l'intestí, però mesos després, la prevalença en intestí baixa i incrementa en els òrgans hematopoètics i l'estómac. Els signes clínics de la infecció van consistir en una reducció significativa del creixement, emaciació, i pal·lidesa de les parets intestinals. A nivell cel·lular, en els casos més greus es va observar hipercelularidad en l'epiteli intestinal i proliferació de cèl·lules rodlet, un elevat nombre de limfòcits en la base de l'epiteli i infiltració de granulòcits acidòfils en l'epiteli intestinal. Finalment es van provar diverses formes de transmissió horitzontal de E. nucleophila (cohabitació, efluent, intubació oral i anal) amb per a desenvolupar un model de manteniment in vivo. Es va aconseguir la transmissió el paràsit per totes les vies, però amb una disminució de prevalença al llarg del temps. Variables com la temperatura, la dosi, i l'estat dels peixos donants semblen ser més determinants que la ruta seleccionada per a la transmissió. Entre les rutes provades, la intubació anal sembla ser la més prometedora, però cap d'elles va ser capaç de reproduir els signes clínics observats en les infeccions naturals. / [EN] Aquaculture production is hampered by the emergence of parasite diseases in fish farming systems. Among them, in Sparus aurata, there are two important enteric parasites described: Enteromyxum leei (Myxozoa) Enterospora nucleophila (Microsporidia). To date, no in vitro culture has been established for either parasite, and only for E. leei was it possible to establish a model for maintaining the infection in vivo. The aim of this thesis is to gain new knowledge about these parasites and their relationship with the host, also the basic foundations for generating solutions that can be applied in aquaculture. The general objective for E. leei was to study the acquired immunity induced in gilthead bream and the possibility of generating diagnostic tools and vaccines against this disease. To this end, resistance against the parasite was assessed with a second exposure against the parasite, which showed a resistance for at least 16 months. Besides resistance seemed to be correlated with high levels of specific immunoglobulin (Ig) M in blood, and a high expression of Igs, in particular, the soluble forms, even before re-exposure to the parasite. The next step was refining the protocol for effluent infection with E. leei by studying infection at different exposure time points, temperatures and population densities. The results showed that one week of exposure is sufficient to spread E. leei infection by effluent, regardless of temperature. After demonstrating the resistance against E. leei, and with a refined infection model, a passive immunization assay was performed. The results showed that the serum with specific antibodies effectively slows down the invasion of the gut by the parasite and reduces the symptoms of the disease. At the same time, the analysis of the repertoire of the variable regions of intestinal IgM and IgT showed an induction of a polyclonal response in B cells. On the basis of these results, a research was carried out for E. leei antigens that could have use as candidates for the production of vaccines (proteomic study) or diagnostic tools (in silico study) using the parasite transcriptomic data. To do this, a de novo transcriptome was assembled using a mixed sample of gilthead sea bream and parasite, with a posterior filtrate of the sequences. The In silico and proteomic analysis search resulted in 7 and 12 transcripts, respectively, which are being used for diagnostic and vaccine production. The starting point was more basic in E. nucleophila studies, since this is a recently described disease. The samples of this parasite can only be obtained from natural outbreaks in fish farms. Therefore, first study was carried out to characterize the pathology of the infection of naturally infected fish. In the early stages of the infection, the parasite is mainly located in the intestine, but months later, the prevalence is lower in the intestine and increases in the hematopoietic organs and the stomach. Clinical signs of infection were significant reduction in growth, wasting, and intestinal walls paleness. At the cellular level, in the most severe cases hypercellularity in the intestinal epithelium, proliferation of rodlet cells, high number of lymphocytes at the base of the epithelium and infiltration of acidophilic granulocytes in the intestinal epithelium were observed. Finally, horizontal transmission of E. nucleophila was tried using different transmission methods: cohabitation, effluent, and oral and anal intubation. Transmission of the parasite was achieved with all routes, but there was a decrease in prevalence over time in all cases except for the anal route. Variables such as temperature, dose, and the status of the donor fish appear to be more important than the selected route. Among the routes tested, anal intubation seemed to be the most promising, as it was sustained over a longer period of time, but none of them was able to reproduce the same clinical signs of infection observed in natural infections. / The authors kindly acknowledge the collaboration of anonymous fish farming companies allowing access to the animals during the disease outbreaks. We thank J. Monfort and L. Rodríguez (IATS-CSIC) for the technical assistance on histological processing.This work has been carried out with financial support from the European Union and the Spanish Ministry of Economy and Competitiveness (MINECO) under grant projects ParaFishControl (H2020-634429) and AGL2013-R-48560-C2-2-R, respectively. APS was contracted under ParaFishControl project. Primer sequences and access to the gilthead sea bream transcriptomic database were kindly provided by Prof. J. Pérez-Sánchez of the IATS- Nutrigenomics group. The authors thank I. Vicente for fish maintenance and technical assistance during samplings. The authors thank P. Boudinot (INRAE) for his help in designing and interpreting the immunoglobulin repertoire study and results, J. Pérez-Sánchez (IATS-CSIC) for providing access to the gilthead sea bream genome sequences to perform the repertoire analysis.This work was funded by the European Research Council (ERC Consolidator Grant 2016 725061 TEMUBLYM). / Picard Sánchez, MA. (2021). Control of enteric parasitic diseases of farmed gilthead sea bream: New insights into Enteromyxum leei (Myxozoa) and Enterospora nucleophila (Microsporidia) infections [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/167035 / Compendio

Koffein (1,3,7-Trimethylxanthin) und Coprostanol (5beta-cholestan-3beta-ol) wurden im Berliner Oberflächenwasser nachgewiesen. Ihre Konzentrationen korrelierten mit dem Verunreinigungsgrad der Proben, was nahelegt, dass sie sich als Marker für menschliche Aktivität eignen. Bemerkenswerterweise wurde Koffein in jeder einzelnen Oberflächenwasserprobe oberhalb der Bestimmungsgrenze von 0,025 µg/L gefunden. Um Oberflächenwasserproben in größeren Serien zu untersuchen, war die Entwicklung zweier neuer Methoden erforderlich: ein Immunoassay, basierend auf einem monoklonalen Antikörper für Koffein und eine dispersive flüssig-flüssig Mikroextraktionsmethode (DLLME), gefolgt von Flüssigkeitschromatographie gekoppelt mit Tandem-Massenspektrometrie (LC-MS/MS) für Coprostanol. Der entwickelte Koffein-Immunoassay zeigt die beste je erhaltene Nachweisgrenze für Koffein (0,001 µg/L), erlaubt Hochdurchsatz-Analysen und erfordert keine Probenvorbereitung. Der Assay wurde auch erfolgreich für die Messung von Koffein in Getränken, Haarwaschmitteln, Koffeintabletten und menschlichem Speichel angewendet. Antikörper gegen Coprostanol sind nicht kommerziell erhältlich. Eine neue Strategie Anti-Coprostanol-Antikörper zu generieren wurde erarbeitet, die eine analoge Verbindung – Isolithocholsäure (ILA) – als Hapten verwendet, mit der eine Gruppe von Mäusen immunisiert wurde. Ein polyklonales Anti-ILA-Serum wurde produziert, welches Coprostanol bindet, aber die niedrige Affinität erlaubte nicht den Aufbau eines Immunoassays, der die Messung von Umweltkonzentrationen des Anayten (im Bereich ng/L) zulässt. Spezifische Anti-ILA-Immunglobuline G wurden auch in den Faeces der Mäuse gefunden. Coprostanol wurde in den Wasserproben durch die Verwendung einer neuentwickelten LC-MS/MS-Methode unter APCI-Ionisation (atmospheric pressure chemical ionisation) gemessen. Konzentrationen oberhalb von 0,1 µg/L wurden nach Voranreicherung der Probe mittels DLLME bestimmt. / Caffeine (1,3,7-trimethylxanthine) and coprostanol (5beta-cholestan-3beta-ol) were detected in samples of Berlin’s surface water. Their concentrations correlated with the contamination status of the samples, suggesting their usefulness as markers of human activity. Remarkably, caffeine concentrations were always well above the limit of quantitation of 0.025 µg/L. In order to screen surface water samples in larger series, the development of two novel methods was required: a monoclonal antibody-based immunoassay for caffeine and a dispersive liquid-liquid microextraction (DLLME) method, followed by liquid chromatography tandem mass spectrometry (LC-MS/MS) for coprostanol. The caffeine immunoassay developed shows the best analytical limit of detection (LOD) obtained so far for caffeine (0.001 µg/L), allows high-throughput analysis, and does not require sample pre-treatment. The assay was also successfully employed to measure caffeine in beverages, shampoos, caffeine tab-lets, and human saliva. Antibodies to coprostanol are not commercially available. A new strategy to generate anti-coprostanol antibodies was elaborated using an analogous com-pound as hapten – isolithocholic acid (ILA) – and immunizing a group of mice. A polyclonal anti-ILA serum was produced, which binds coprostanol but the low affinity did not permit setting up an immunoassay to measure environmental concentrations of the analyte (in the range of ng/L). Specific anti-ILA immunoglobulin G were also found in the faeces of the immunized mice. Coprostanol was quantified in the water samples using a newly developed LC-MS/MS method using atmospheric pressure chemical ionisation (APCI). Concentrations above 0.1 µg/L were determined after sample preconcentration using DLLME. This extraction method also proved to be successful for enrichment of coprostanol-related compounds such as cholesterol, cholestanol, cholestanone, ergosterol, and stigmasterol.